Quick Asked: Momenta Pharmaceuticals Contact Us?
Last update: 26 Apr, 2024 
258 Views
Who bought out momenta pharmaceuticals? NEW BRUNSWICK, N.J., August 19, 2020 – Johnson & Johnson (NYSE:JNJ) today announced it has entered into a definitive agreement to acquire Momenta Pharmaceuticals, Inc. (Momenta), a company that discovers and develops novel therapies for immune-mediated diseases, in an all cash transaction for approximately $6.5 billion.Why work for momenta? Having started off exclusively staffing the Financial Industry with leading contingent workforce, Momenta now operates across multiple sectors globally and continues to grow and innovate to best service our clients and associates. Building on its reputation in the UK, Momenta’s first global expansion was into Australia in 2016.Why did momenta open an office in sydney? Having identified the demand for increased contingent workforce after increased regulation in the financial services market came into effect, Momenta opened offices in Sydney to best be able to service our global clients’ needs in the territory.Why momenta and johnson johnson? “The Momenta team has made excellent progress in developing its medicines for rare diseases, and we look forward to combining our expertise and resources with theirs to increase that scope,” said Mathai Mammen, M.D., Ph.D., Global Head of Janssen Research & Development, Johnson & Johnson.
Listing Results Momenta Pharmaceuticals Contact Us? Question Answers
Momenta Pharmaceuticals Crunchbase Company Profile ...
Contact Email [email protected] Phone Number (617)621-0431 Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, such as heparan-sulfate proteoglycans.
Momenta Pharmaceuticals, Inc. Home
Momenta Pharmaceuticals Overview, News & ...
Momenta Pharmaceuticals Announces Completion of Proposed Sale to Johnson & Johnson CAMBRIDGE, Mass., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA, “Momenta” or the “Company”), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated ...